Clinical Trials Logo

Clinical Trial Summary

Occupational asthma (OA) caused by high molecular weight (HMW) substances have been shown to induce predominantly an eosinophilic inflammation. In contrast, OA caused by low molecular weight (LMW) substances results in a neutrophilic inflammation. In addition, data regarding phenotype of lymphocytes in OA caused by HMW and LMW substances are scarce. The use of a new equipment will allow the realization of specific standardized bronchial challenges (BC) to occupational agents. Thus, we propose to study in more detail the cellular mechanisms involved during BC to HMW and LMW occupational agents in a double-blind placebo controlled study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01783873
Study type Interventional
Source University Hospital, Strasbourg, France
Contact
Status Terminated
Phase N/A
Start date September 2012
Completion date December 12, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03568305 - Characterization of Phenotypes of Occupational Asthma
Completed NCT01096537 - Early Incidence of Occupational Asthma Among Bakers, Pastry-makers and Hairdressers N/A